These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20809835)

  • 21. Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era.
    Flamaing J; Verhaegen J; Vandeven J; Verbiest N; Peetermans WE
    J Antimicrob Chemother; 2008 Jan; 61(1):143-9. PubMed ID: 17999974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pays de la Loire Pneumococcus Observatory: antimicrobial resistance of Streptococcus pneumoniae in 2007].
    Kempf M; Kowalczyk F; Gaultier du Perray C; Andorin P; Bichier E; Bonnaudet G; Chambreuil G; Cheviet G; Darreau JY; De Gastines G; Jan D; Jaouen E; Jouble F; Juvin ME; Langeard MM; Le Brun C; Le Reste JY; Lureau B; Mir E; Mozas M; Tharreau T; Varache C; Cottin J; Joly-Guillou ML
    Pathol Biol (Paris); 2010 Feb; 58(1):89-94. PubMed ID: 19892480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
    Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
    Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
    Fenoll A; Aguilar L; Granizo JJ; Giménez MJ; Aragoneses-Fenoll L; Mendez C; Tarragó D
    J Antimicrob Chemother; 2008 Dec; 62(6):1430-3. PubMed ID: 18819966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.
    Charfi F; Smaoui H; Kechrid A
    Vaccine; 2012 Dec; 30 Suppl 6():G18-24. PubMed ID: 23228353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology.
    Dortet L; Ploy MC; Poyart C; Raymond J;
    Diagn Microbiol Infect Dis; 2009 Sep; 65(1):49-57. PubMed ID: 19679235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic susceptibility of invasive Streptococcus pneumoniae in Wisconsin, 1999.
    Belongia EA; Proctor M; Vandermause M; Ahrabi-Fard S; Knobloch MJ; Keller P; Bergs R; Chyou PH; Davis JP
    WMJ; 2000 Aug; 99(5):55-9. PubMed ID: 11043072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution.
    Saha SK; Naheed A; El Arifeen S; Islam M; Al-Emran H; Amin R; Fatima K; Brooks WA; Breiman RF; Sack DA; Luby SP;
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S75-81. PubMed ID: 19191622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective epidemiologic surveillance of invasive pneumococcal disease and pneumonia in children in San José, Costa Rica.
    Arguedas A; Abdelnour A; Soley C; Jimenez E; Jimenez AL; Ramcharran D; Porat N; Dagan R; Gray S; Rodgers GL
    Vaccine; 2012 Mar; 30(13):2342-8. PubMed ID: 22300725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
    Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
    Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 predicting the future impact of the universal childhood conjugate vaccine program.
    Watson M; Roche P; Bayley K; Bell JM; Collignon P; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Smith HV; Brown M; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2004; 28(4):455-64. PubMed ID: 15745392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment.
    Stephens DS; Zughaier SM; Whitney CG; Baughman WS; Barker L; Gay K; Jackson D; Orenstein WA; Arnold K; Schuchat A; Farley MM;
    Lancet; 2005 Mar 5-11; 365(9462):855-63. PubMed ID: 15752529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
    Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P;
    Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine.
    Dias R; Caniça M
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):35-42. PubMed ID: 17854472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel.
    Porat N; Barkai G; Jacobs MR; Trefler R; Dagan R
    J Infect Dis; 2004 Feb; 189(3):385-92. PubMed ID: 14745695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pneumococcal serotype distribution and antimicrobial resistance in Chinese children hospitalized for pneumonia.
    Yao KH; Wang LB; Zhao GM; Zheng YJ; Deng L; Huang JF; Wang JX; Zhao RZ; Deng QL; Hu YH; Yu SJ; Yang YH; Young M
    Vaccine; 2011 Mar; 29(12):2296-301. PubMed ID: 21276441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine.
    Kuo CY; Hwang KP; Hsieh YC; Cheng CH; Huang FL; Shen YH; Huang YC; Chiu CH; Chen PY; Lin TY
    Vaccine; 2011 Jul; 29(32):5171-7. PubMed ID: 21621578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline epidemiology of Streptococcus pneumoniae serotypes in Canada prior to the introduction of the 13-valent pneumococcal vaccine.
    Adam HJ; Karlowsky JA; Nichol KA; Gilmour MW; Hoban DJ; Embree J; Zhanel GG
    Microb Drug Resist; 2012 Apr; 18(2):176-82. PubMed ID: 22204595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.